Vancouver, British Columbia--(Newsfile Corp. - May 12, 2021) - Lobe Sciences (CSE: LOBE) today announced that Philip Young, CEO and Director, will be attending the Q2 Virtual Investor Summit.
| Event | Q2 Investor Summit |
| Date | May 17-18th, 2021 |
| Presentation | May 18th at 10:15 AM ET |
| Location | https://zoom.us/webinar/register/WN_9O2Bo2GAS-Ks6W5cFJKFWQ |
About Lobe Sciences
Lobe is a life sciences company focused on psychedelic medicines. The Company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.
For further information:
Lobe Sciences
Philip Young CEO & Director
(949) 505-5623
[email protected]
About the Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.
To request complimentary investor registration: please visit our website at www.investorsummitgroup.com.
Contact:
Sasha Murray at [email protected]